10 Einträge gefunden

1. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections

   1. Dietz, Julia
   2. Spengler, Ulrich
   3. Müllhaupt, Beat
   4. Schulze Zur Wiesch, Julian
   5. Piecha, Felix
   6. Mauss, Stefan
   7. Seegers, Barbara

   2021 - Forschungsinformationssystem des UKE
2. Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era

   1. Ingiliz, Patrick
   2. Wehmeyer, Malte H
   3. Boesecke, Christoph
   4. Schulze Zur Wiesch, Julian
   5. Schewe, Knud
   6. Lutz, Thomas
   7. Baumgarten, Axel

   2020 - Forschungsinformationssystem des UKE
3. Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?

   1. Bischoff, Jenny
   2. Boesecke, Christoph
   3. Ingiliz, Patrick
   4. Berger, Florian
   5. Simon, Karl-Georg
   6. Lutz, Thomas
   7. Schewe, Carl K

   2020 - Forschungsinformationssystem des UKE
4. Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study

   1. Schulte, Bernd
   2. Schmidt, Christiane S
   3. Manthey, Jakob
   4. Strada, Lisa
   5. Christensen, Stefan
   6. Cimander, Konrad
   7. Görne, Herbert

   2020 - Forschungsinformationssystem des UKE
5. Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)

   1. Christensen, Stefan
   2. Buggisch, Peter
   3. Mauss, Stefan
   4. Böker, Klaus Hw
   5. Müller, Tobias
   6. Klinker, Hartwig
   7. Zimmermann, Tim

   2019 - Forschungsinformationssystem des UKE
6. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study

   1. Berg, Thomas
   2. Simon, Karl-Georg
   3. Mauss, Stefan
   4. Schott, Eckart
   5. Heyne, Renate
   6. Klass, Dietmar M
   7. Eisenbach, Christoph

   2017 - Forschungsinformationssystem des UKE
7. Effect of antiviral therapy for HCV on lipid levels

   1. Mauss, Stefan
   2. Berger, Florian
   3. Wehmeyer, Malte H
   4. Ingiliz, Patrick
   5. Hueppe, Dietrich
   6. Lutz, Thomas
   7. Simon, Karl G

   2017 - Forschungsinformationssystem des UKE
8. Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection

   1. Boesecke, Christoph
   2. Ingiliz, Patrick
   3. Berger, Florian
   4. Lutz, Thomas
   5. Schewe, Knud
   6. Schulze Zur Wiesch, Julian
   7. Baumgarten, Axel

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
9. Cytokine and Chemokine Signature in Elite versus Viremic Controllers infected with HIV

   1. Platten, Martin
   2. Jung, Norma
   3. Trapp, Susanna
   4. Floßdorf, Pia
   5. Meyer-Olson, Dirk
   6. Schulze Zur Wiesch, Julian
   7. Stephan, Christoph

   2016 - Forschungsinformationssystem des UKE
10. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

    1. Roeder, Claudia
    2. Jordan, Sabine
    3. Schulze Zur Wiesch, Julian
    4. Pfeiffer-Vornkahl, Heike
    5. Hueppe, Dietrich
    6. Mauss, Stefan
    7. Zehnter, Elmar

    2014 - Forschungsinformationssystem des UKE